Interview on the Rapid Discovery of SARS-CoV-2 Neutralizing Antibodies
Watch Interview
Bamlanivimab (LY-CoV555) is the First COVID-19 Therapeutic Made Available to the Public by the FDA
Read More
Carterra Supercharges Antibody Discovery Workflows for LakePharma with High-Throughput SPR
Read More
Carterra’s Scientist to Scientist Series: Daniel Bedinger and Tom Yuan from Twist Bioscience
Watch Interview
Carterra Helps Provide Breakthrough Analysis for Understanding the Immunity of COVID-19 Patients by Scientists in Europe
Watch the Webinar
Carterra has been Selected by the Gates Foundation to Help Solve the COVID-19 Pandemic
Watch Video
Carterra Eliminates Bottlenecks in mAb Drug Discovery
Read More
Addressing Viral Pandemics Such as COVID-19 Using the Carterra LSA
Read More
Speeding Antibody Screening for Drug Development with Carterra’s LSA
Read More
Discovering an Antibody’s Therapeutic Fingerprint Using the Carterra LSA
Read More